These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24533717)

  • 41. Advances in pharmacogenetics and pharmacogenomics.
    Vesell ES
    J Clin Pharmacol; 2000 Sep; 40(9):930-8. PubMed ID: 10975065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
    Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
    Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetics in clinical dermatology.
    Ameen M; Smith CH; Barker JN
    Br J Dermatol; 2002 Jan; 146(1):2-6. PubMed ID: 11841360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
    Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
    OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
    Fatunde OA; Brown SA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.
    de Andrés F; Sosa-Macías M; Lazalde-Ramos BP; Naranjo ME; Tarazona-Santos E; Llerena A;
    Drug Metabol Drug Interact; 2013; 28(3):135-46. PubMed ID: 23787463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of pharmacogenetics of adverse drug reactions in elderly people.
    Cardelli M; Marchegiani F; Corsonello A; Lattanzio F; Provinciali M
    Drug Saf; 2012 Jan; 35 Suppl 1():3-20. PubMed ID: 23446782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laying the foundations for personalized medicines.
    Marshall A
    Nat Biotechnol; 1997 Oct; 15(10):954-7. PubMed ID: 9335043
    [No Abstract]   [Full Text] [Related]  

  • 51. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.
    Pilgrim JL; Gerostamoulos D; Drummer OH
    Forensic Sci Med Pathol; 2011 Jun; 7(2):162-84. PubMed ID: 21052868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.
    Oliveira E; Pereira R; Amorim A; McLeod H; Prata MJ
    Pharmacogenomics; 2009 Sep; 10(9):1413-22. PubMed ID: 19761365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.
    B Tata E; A Ambele M; S Pepper M
    Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32858798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.
    Klotz U
    Clin Pharmacokinet; 2007; 46(4):271-9. PubMed ID: 17375979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in the Pharmacogenomics of Adverse Drug Reactions.
    Collins SL; Carr DF; Pirmohamed M
    Drug Saf; 2016 Jan; 39(1):15-27. PubMed ID: 26650062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.
    Cressey TR; Lallemant M
    Infect Genet Evol; 2007 Mar; 7(2):333-42. PubMed ID: 17045554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.
    de Jong LM; Jiskoot W; Swen JJ; Manson ML
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33339226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.
    Wilffert B; Swen J; Mulder H; Touw D; Maitland-Van der Zee AH; Deneer V;
    Int J Clin Pharm; 2011 Feb; 33(1):3-9. PubMed ID: 21365387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.